BIOYF (Biosyent) Change In Other Working Capital : $-0.02 Mil (TTM As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Biosyent Change In Other Working Capital?

Biosyent's Change In Other Working Capital for the quarter that ended in Mar. 2025 was $-0.48 Mil. It means Biosyent's Other Working Capital declined by $0.48 Mil from Dec. 2024 to Mar. 2025 .

Biosyent's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $0.48 Mil. It means Biosyent's Other Working Capital increased by $0.48 Mil from Dec. 2023 to Dec. 2024 .

Biosyent Change In Other Working Capital Historical Data

The historical data trend for Biosyent's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyent Change In Other Working Capital Chart

Biosyent Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

Get a 7-Day Free Trial

0.65

-0.60

-0.11

-0.02

0.48

Biosyent Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Other Working Capital	Get a 7-Day Free Trial															0.03	-0.02	0.26	0.23	-0.48

Biosyent Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02 Mil.

Biosyent Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Biosyent's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyent Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (OTCPK:BIOYF) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

RX:Canada

Address

2476 Argentia Road, Suite 402, Toronto, Mississauga, ON, CAN, L5N 6M1

Website

http://www.biosyent.com

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.